LILI GUNDELACH

Lili holds a bachelor’s and a master’s degree in Molecular and Cellular Biology from the University of Glasgow, Scotland. During her studies, her main area of interest was Immunotherapy and Antibody Engineering.
Lili has experience as a laboratory-based researcher focusing on novel drug design at pharmaceutical companies and in academia. Since moving to Hannover, Germany in 2019, she has worked as a freelance scientific writer, collaborating with the European Patients’ Academy on Therapeutic Innovation (EUPATI) among other organisations. Lili speaks English, Hungarian, conversational German and Japanese.